Interestingly, breast tumor-bearing mice on anti-CTLA4 therapy when placed on a low-salt diet demonstrated decreased peripheral circulatory levels of inflammatory cytokines (IFNγ and IL-1β) and reduced lung infiltrating of inflammatory immune cells along with reduced tumor progression. Here, CTLA4 is linked to breast neoplasm.